BIO Key Net Worth
BIO Key Net Worth Breakdown | BKYI |
BIO Key Net Worth Analysis
BIO Key's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including BIO Key's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of BIO Key's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform BIO Key's net worth analysis. One common approach is to calculate BIO Key's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares BIO Key's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing BIO Key's net worth. This approach calculates the present value of BIO Key's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of BIO Key's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate BIO Key's net worth. This involves comparing BIO Key's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into BIO Key's net worth relative to its peers.
Enterprise Value |
|
To determine if BIO Key is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding BIO Key's net worth research are outlined below:
| BIO Key is way too risky over 90 days horizon | |
| BIO Key has some characteristics of a very speculative penny stock | |
| BIO Key appears to be risky and price may revert if volatility continues | |
| BIO Key has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 7.75 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 3.44 M. | |
| BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Latest headline from finance.yahoo.com: BIO-key Partners with California Ed Tech JPA to Make its Identity and Access Management Solutions Available to 195 Member Institutions Serving Over 2.6M Students |
BIO Key uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in BIO Key International. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to BIO Key's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know BIO Key's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as BIO Key is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BIO Key International backward and forwards among themselves. BIO Key's institutional investor refers to the entity that pools money to purchase BIO Key's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goss Wealth Management Llc | 2024-12-31 | 4.0 | Wells Fargo & Co | 2024-12-31 | 3.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 | Abich Financial Wealth Management Llc | 2024-09-30 | 0.0 | Headlands Technologies Llc | 2024-12-31 | 0.0 | Armistice Capital, Llc | 2024-12-31 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 20.3 K | Virtu Financial Llc | 2024-12-31 | 15.5 K | Geode Capital Management, Llc | 2024-12-31 | 11.2 K | Xtx Topco Ltd | 2024-12-31 | 10.2 K |
Follow BIO Key's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M.Market Cap |
|
Project BIO Key's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.47) | (2.59) | |
| Return On Capital Employed | (7.79) | (7.40) | |
| Return On Assets | (1.70) | (1.78) | |
| Return On Equity | (9.21) | (8.75) |
When accessing BIO Key's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures BIO Key's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of BIO Key's profitability and make more informed investment decisions.
Evaluate BIO Key's management efficiency
BIO Key International has return on total asset (ROA) of (0.5568) % which means that it has lost $0.5568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5811) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -2.59. The BIO Key's current Return On Capital Employed is estimated to increase to -7.4. As of now, BIO Key's Net Tangible Assets are increasing as compared to previous years. The BIO Key's current Intangibles To Total Assets is estimated to increase to 0.37, while Non Current Assets Total are projected to decrease to under 2.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.71 | 1.79 | |
| Tangible Book Value Per Share | (0.55) | (0.58) | |
| Enterprise Value Over EBITDA | (0.18) | (0.17) | |
| Price Book Value Ratio | 1.42 | 1.49 | |
| Enterprise Value Multiple | (0.18) | (0.17) | |
| Price Fair Value | 1.42 | 1.49 | |
| Enterprise Value | 5 M | 4.7 M |
The strategic vision of BIO Key International management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue 0.6064 | Revenue | Quarterly Revenue Growth (0.41) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BIO Key insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BIO Key time-series forecasting models is one of many BIO Key's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BIO Key's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
BIO Key Earnings per Share Projection vs Actual
BIO Key Corporate Management
| Cecilia Welch | Chief Officer | Profile | |
| Akintunde Jeje | Managing Africa | Profile | |
| Alex Rocha | Managing EMEA | Profile | |
| Mira LaCous | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.